Investing
Top Analyst Upgrades and Downgrades: Ally, Apple, ADP, Brocade, Level 3, Tyco and More
Published:
Stocks surged higher Thursday morning, a day ahead of the unemployment and payrolls report. Investors keep proving over and over that they will buy stocks on pullbacks and that they will seek value and overlooked stocks every time they can. 24/7 Wall St. reviews dozens of analyst research reports each day to find new investment and trading ideas for our readers. Some analyst reports cover stocks to buy, while others cover stocks to sell or avoid.
Source: Thinkstock
These are this Thursday’s top analyst upgrades, downgrades and initiations.
Affymetrix Inc. (NASDAQ: AFFX) was raised to Neutral from Underweight at J.P. Morgan
Ally Financial Inc. (NYSE: ALLY) was raised to Buy from Neutral at Bank of America Merrill Lynch.
Apple Inc. (NASDAQ: AAPL) was reiterated as Outperform and the price target was raised to $140 from $130 (versus a $119.56 close) at Credit Suisse.
Automatic Data Processing Inc. (NASDAQ: ADP) was downgraded to Market Perform from Outperform at BMO Capital Markets.
BankUnited Inc. (NYSE: BKU) was started as Overweight with a $33 price target (versus a $29.44 close) at Barclays.
ALSO READ: The Outlook on Apple’s All-Time High
Brocade Communications Systems Inc. (NASDAQ: BRCD) was raised to Buy from Sell at Citigroup.
Fifth Third Bancorp (NASDAQ: FITB) was downgraded to Neutral from Buy at Merrill Lynch.
IMAX Corp. (NYSE: IMAX) was downgraded to Neutral from Overweight at J.P. Morgan.
KeyCorp (NYSE: KEY) was raised to Buy from Neutral at Merrill Lynch.
Level 3 Communications Inc. (NYSE: LVLT) rose after earnings, and Canaccord Genuity reiterated its Buy rating and raised its price target to $63 from $55.
Navistar International Corp. (NYSE: NAV) was downgraded to Underweight from Overweight at J.P. Morgan.
Neurocrine Biosciences Inc. (NASDAQ: NBIX) was started as Outperform at Baird.
Ralph Lauren Corp. (NYSE: RL) has seen three downgrades: to Neutral from Buy at Citigroup, to Neutral from Buy at UBS and to Neutral from Buy at Goldman Sachs.
ALSO READ: Why Apple Is Selling Billions in Debt Again
Sarepta Therapeutics Inc. (NASDAQ: SRPT) was started as Neutral by SunTrust.
Tyco International Ltd. (NYSE: TYC) was defended at Argus with a Buy rating reiterated and with a $48 price target. Shares closed at $41.41 on Wednesday.
In case you missed Wednesday’s top analyst upgrades and downgrades, they were in Coupons.com, Dean Foods, Hilton, Isis Pharmaceutical, National Oilwell Varco, Stratasys and a dozen or so others.
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
